---
title: "ASK PHARM: Su Yang Investment plans to reduce its holdings of no more than 1.5% of the company's shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/250615776.md"
description: "According to the announcement from ASK PHARM, Su Yang Investment plans to reduce its holdings in the company by no more than 13.9224 million shares, not exceeding 1.5% of the company's total share capital, through centralized bidding and block trading within 90 calendar days after the 15 trading days from the date of this announcement"
datetime: "2025-07-29T13:27:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/250615776.md)
  - [en](https://longbridge.com/en/news/250615776.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/250615776.md)
generator: "portal-rs"
---

# ASK PHARM: Su Yang Investment plans to reduce its holdings of no more than 1.5% of the company's shares

According to the announcement from Zhitong Finance APP, ASK PHARM (002755.SZ) announced that Su Yang Investment plans to reduce its holdings of the company's shares by no more than 13.9224 million shares, which does not exceed 1.5% of the company's total share capital, within 90 calendar days after 15 trading days from the date of this announcement through centralized bidding and block trading

### Related Stocks

- [002755.CN](https://longbridge.com/en/quote/002755.CN.md)

## Related News & Research

- [In defence of The Hundred, by co-chair of Welsh Fire](https://longbridge.com/en/news/296471479.md)
- [Sinopharm sells 30.13% stake in Guorui Pharma to Shanghai Shyndec for RMB 240.07 million](https://longbridge.com/en/news/296367279.md)
- [19:16 ETAG.AL Crowned Esports World Cup 2026 Club Champion After Landmark Competition in Paris](https://longbridge.com/en/news/296712807.md)
- [Olympics-LA28 Olympic ticket sales top 6 million; next public sale set for 2027](https://longbridge.com/en/news/296621123.md)
- [Motor racing-IndyCar takes to Washington streets for landmark Freedom 250](https://longbridge.com/en/news/296529352.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**